LENSAR, Inc.LNSRNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P17
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2024-13.19%
2023-48.04%
2022-4.40%
202163.62%
2020-0.21%
2019171.88%
20180.00%